Compagnie Lombard Odier SCmA’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-100
Closed -$2K 532
2020
Q2
$2K Hold
100
﹤0.01% 512
2020
Q1
$1K Hold
100
﹤0.01% 490
2019
Q4
$2K Hold
100
﹤0.01% 497
2019
Q3
$1K Hold
100
﹤0.01% 514
2019
Q2
$2K Hold
100
﹤0.01% 501
2019
Q1
$2K Buy
+100
New +$1.77K ﹤0.01% 545

Other funds holding CLLS

Compagnie Lombard Odier SCmA's CLLS Position: Q3 2020 in Review

Compagnie Lombard Odier SCmA sold out of Cellectis (CLLS) in Q3 2020, closing a stake of 100 shares — an estimated $2K sold.

Compagnie Lombard Odier SCmA first reported a position in CLLS in Q1 2019 and held it in 6 quarters. The position peaked at $2K in Q2 2020. 74 funds tracked by Wall St. Rank hold CLLS as of Q3 2020.

  • Compagnie Lombard Odier SCmA reported no remaining Cellectis position as of Q3 2020 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 100 Cellectis shares in Q3 2020, an estimated $2K.
  • Compagnie Lombard Odier SCmA first reported a position in Cellectis in Q1 2019 and held it in 6 quarters.
  • Compagnie Lombard Odier SCmA's Cellectis position peaked at $2K in Q2 2020.
  • 74 funds tracked by Wall St. Rank held Cellectis as of Q3 2020.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2020, filed 12 Nov 2020.